Found: 1
Select item for more details and to access through your institution.
A Phase II Study of Durvalumab in Combination with Tremelimumab in Patients with Rare Cancers.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. e1499, doi. 10.1002/onco.13798
- By:
- Publication type:
- Article